Discontinued Operations (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Regenerative Medicine - China segment [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Revenue	$ 52,300
Disposal Group, Including Discontinued Operation, Costs of Goods Sold	30,600
Disposal Group Including Discontinued Operation Research and Development	103,300
Disposal Group Including Discontinued Operation Selling General and Administrative	497,300
Disposal Group, Including Discontinued Operation, Operating Expense	6,800
Loss on Exit of Segment	1,138,000
Pharmaceutical Manufacturing - China business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	$ 8,457,500
CBH Acquisition LLC [Member] | Equity Purchase Agreement [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity Method Investment, Ownership Percentage	51.00%